Open access · US-GOV via ClinicalTrials.gov Clinical trial

VITAL-Age Trial (iVS-1 Investigation for Targeting Aging and Longevity)

Authors not listed

Synbiotic Health · 2026

Dysbiosis Human Randomized controlled trial

Abstract

This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation of aging-related biological pathways through the gut microbiome may influence health-related outcomes.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-07-02 MST

Cite this

APA

Anonymous. (2026). VITAL-Age Trial (iVS-1 Investigation for Targeting Aging and Longevity). <em>Synbiotic Health</em>. https://clinicaltrials.gov/study/NCT07407894

Vancouver

Anonymous. VITAL-Age Trial (iVS-1 Investigation for Targeting Aging and Longevity). Synbiotic Health. 2026.

BibTeX

@misc{anon2026VITALA, title = {VITAL-Age Trial (iVS-1 Investigation for Targeting Aging and Longevity)}, author = {Anonymous}, journal = {Synbiotic Health}, year = {2026}, }